Valirx Share Discussion Threads

[sooty snipes] 07/12/2022 15:12

Ben, how do you know Nick Slater has bought more?

[412069] 07/12/2022 14:40

Buying a started for next week’s webinar,
maybe news between now and then.

[ben gibbons] 07/12/2022 14:35

Muppet boy is back ;-)Get back in your cage chump!

[ben gibbons] 07/12/2022 13:53

Well Slater is confident enough to buy more!

[ben gibbons] 07/12/2022 10:50

Lol Blackhorse23 following me to Val bb now!Hilarious and sad :-)

[ben gibbons] 07/12/2022 10:44

Captain Rampy Pants is here!

[ben gibbons] 07/12/2022 10:43

Have not got the minerals to sell up and move on but happy to sit on massive losses here and moan constantly.

Very logical.

[ben gibbons] 07/12/2022 10:42

Mate stop ramping on here no one cares!You have been called out over at currys for this.

[blackhorse23] 07/12/2022 10:42

Switching to CURY , excellent dividend income stock

[vaston] 07/12/2022 10:38

SYME can loan you money without it showing as debt.
It’s about to fly says CEO.

V

[ben gibbons] 07/12/2022 10:35

Go read Adams comments again on LSE. Even he stated the rns content is reflective of some seriously hard work having been performed.I think Adam would know a dam sight more than most of to guys about Val.

[ben gibbons] 07/12/2022 10:30

Lol that is rich coming from captain extra salty!Sold up yet have we?

[francoismyname] 07/12/2022 08:57

Ben living in cuckoo land.

Read the last 100 RNS ‘s over the past 12 years with content and they all read the same. JAM TOMORROW !!!!

[sooty snipes] 07/12/2022 08:52

Ben as much as I'd like to agree but when a good RNS is released the price usually goes up.

[ben gibbons] 07/12/2022 07:27

Great post from pm2022 on LSE.I think people yesterday where shortsighted and did not see the upside and sold off in frustration.For me yesterdays rns was not bad at all.At least it gave an opportunity to buy more cheap :-)

[ben gibbons] 07/12/2022 07:25

PM2022Today 07:12Posts: 1,332Price: 12.50I have had time to reflect and It is clear that the RNS yesterday was on balance very positive. Positives1) Do research on Zai Ahmad. One of the best cancer research scientists and very experienced. Gives our triple negative drug real hope of being successful and shows confidence by the board that they believe this will be worth big money.2) The delay for the evaluation may not be so bad at this moment of time. It was not priced in but means less costs and therefore we have more cash to last roughly another year whilst all these projects come through. The delay to me indicates a decent chance of success as if it was a waste of time it would have been binned.3) As I said earlier and many times we don't need a really large number of drugs like DDDD had. 2 In SPV to take us to the 30s is fine without 201 as we do not want to burn too much cash whilst we grow. The next evaluation result is only 2 months away so the 6 months is not relevant if the next one is successful.4) CLX has commenced full preclinical testing. Larger scale (5g) synthesis has been successfully completed, and the material is undergoing formulation optimisation. The initial CLX001 testing was conducted using a bench-scale formulation which requires optimisation for industrial and eventual commercial use. Regulatory planning activities have been commenced.5) VAL301 is undergoing preclinical cell-based assays under supervision by ValiRx to confirm the breadth of biological pathways involved. Utilising newer cell-based analytical technologies, this programme of work is designed to complement historical data and to move the project forwards towards formal preclinical studies. Additional opportunities to further optimise the drug candidate have been identified and work is ongoing to assess the potential for additional patent filings.6) Uncertainty regarding a lab has been removed. A big positive imo. We do not now need a placing to obtain a lab. We can rent a lab which is not expensive and it will save us costs by ensuring our projects are completed in our own labs whilst we also get contracts for external work which covers overheads. This is very positive and also avoids delays moving forwards.7) BC201 has made progress. This was stated last year so should now be imminent.8) Finally the big one VAL201. Suzy is sick of talking about this as the timing is out of her control . It is still on and can come anytime. NegativeDelay for the evaluation. This was highlighted at the top which created panic. As I said we only need two in SPV to get us to 30 s. The next one is not far away so the 6 months is not relevant if the next one is successful. 201 can come this month or next.Overall I feel we should be 20-25p based on the news yesterday and without 201 priced in. If one more is in SPV then 30-40s. I see this as an opportunity to buy. Not much downside as we have sufficient cash and lots of news due as you can see. We will not be 12p in

[jasonpugh] 06/12/2022 23:03

Suzy dily = DD. Aka Delay dily. 😂
Nick slater = TT. Aka the tird😂
Sorry couldn’t help myself. Yo nick thanks for saving me a loss. I always follow your multiple account trades when your congealed twin mark treharne gives you the heads up to sell. Love you nick. Can i have my skittles now.👍

[ben gibbons] 06/12/2022 21:32

Too many moaning people on here cant see the positives in todays RNS.

At least Adam can and id wager he knows a dam sight more than most do about what is going on!

[ben gibbons] 06/12/2022 21:31

rhubarbmk2Today 17:29Posts: 894Price: 12.50Zai Ahmad is a very good appointment. She worked in the same department as me, at a different time.Naturally, I availed myself to contacting a couple of former colleagues, and they speak of her very highly. This is obviously good news. At least now the Company have three scientists, instead of just one; so I would hope that news flow would be swifter from here on in, regarding, firstly CLX001.Talking of which, they are testing the formulation now, which will be used for the regulatory development work (that's the bit I work in).I know other Companies who would be singing and dancing over this, when complete, because it's no minor event. I've seen reformulation RNSs, in fact.It's not all bad, and it's a shame to be in the low teens again, but that is the nature of AIM; the need for regular news flow (which I believe can be improved); and subsequent the building of market sentiment. I have chatted to Suzy about this today, and will be doing more frequently.

[doerx2] 06/12/2022 18:57

RNS is a load of tosh. They will keep liquidating until the end.

[ben gibbons] 06/12/2022 18:17

From Adam on LSEIf I was unhappy, I'd have sold shares, but in fact I am going to have a wee top up, based on what l've read between the lines of that RNS.

[francoismyname] 06/12/2022 17:10

People finally smelling the coffee.

Next raise at 4p. A 10p raise is a pipe dream from here .